These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 13982681)
21. Comparison of the effect of the R2 phenothiazine ring substituent on fluphenazine and perphenazine interactions with cyclodextrins. Lutka A; Prange W Acta Pol Pharm; 2005; 62(6):419-25. PubMed ID: 16583980 [TBL] [Abstract][Full Text] [Related]
22. [Levels of serum proteins in psychiatric patients]. Herzog P; Dvoráková M; Zvolský P Cesk Psychiatr; 1984 Jun; 80(3):165-9. PubMed ID: 6478528 [No Abstract] [Full Text] [Related]
23. Evaluation of perphenazine in the treatment of Haitian psychotics. BORDELEAU JM; LAZURE D; DESROSIERS M; DOUYON L; MORIN L Can Psychiatr Assoc J; 1963 Apr; 8():111-5. PubMed ID: 14013872 [No Abstract] [Full Text] [Related]
24. Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis. Habek M; Brinar M; Brinar VV; Poser CM Clin Neurol Neurosurg; 2006 Mar; 108(3):290-4. PubMed ID: 16364539 [TBL] [Abstract][Full Text] [Related]
25. [Neurologic and psychiatric disorders in uremic syndrome]. Susa S; Vujosević K; Kapor G; Dumović B Vojnosanit Pregl; 1967; 24(7):399-402. PubMed ID: 6061223 [No Abstract] [Full Text] [Related]
26. [Notes on the use of a new phenothiazine derivative, perphenazine, in neuro-psychiatric practice]. LARICCHIA R; BASEVI A Minerva Med; 1958 May; 49(39, Suppl.):1993-5. PubMed ID: 13565614 [No Abstract] [Full Text] [Related]
27. [Neurotic states related to cerebral paroxysmal dysrhythmic processes]. de Camargo EM J Bras Psiquiatr; 1970; 19(3):235-44. PubMed ID: 5526369 [No Abstract] [Full Text] [Related]
34. [Trial of perphenazine in psychiatric therapy]. NAVIAU J; BARE C; DUQUESNE JP Ann Med Psychol (Paris); 1963 Jun; 2():98-104. PubMed ID: 13937778 [No Abstract] [Full Text] [Related]
35. Perphenazine in practice. MASON-BROWNE NL Can Med Assoc J; 1958 Dec; 79(12):985-8. PubMed ID: 13608382 [No Abstract] [Full Text] [Related]
36. [Evaluation of the drug Trilafon produced by the Ferrosan company according to experiences of the Psychiatric Clinic of the Academy of Medicine in Lodz]. CWYNAR S; PIONKOWSKI J; SIUCHNINSKA H Neurol Neurochir Psychiatr Pol; 1962; 12():751-2. PubMed ID: 14024422 [No Abstract] [Full Text] [Related]
37. [Possibilities of treating psychiatric disorders with the new psychopharmacological agent "decentan"]. GLATTHAAR GW Munch Med Wochenschr; 1959 Nov; 101():2090-2. PubMed ID: 13828378 [No Abstract] [Full Text] [Related]
38. [Chlorperphenazine in psychiatric and neurological therapy]. HEINRICH K; RICHERT J Nervenarzt; 1960 Mar; 31():128-33. PubMed ID: 14400740 [No Abstract] [Full Text] [Related]
39. [Does decentan mean an advance in psychiatric therapy?]. LIESER H Med Monatsschr; 1960 Jan; 14():18-22. PubMed ID: 14416888 [No Abstract] [Full Text] [Related]